Synthetic Biologics, Inc. (SYN)
Free Cash Flow Growth
24.63%
TTM · Period ending:
SYN Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported24.63%period ending
Latest reported24.63%period ending
SYN TTM Free Cash Flow YoY % (-84.21% → 24.63%)
Year-over-year change
High-resolution chart · PNG
SYN free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 24.6339% | |
| 16.8552% | |
| 1.3815% | |
| -38.3158% | |
| -48.7756% | |
| -45.9596% | |
| -37.0346% | |
| -6.0051% | |
| 11.1542% | |
| 18.5161% | |
| 27.75% | |
| 12.254% | |
| 6.8116% | |
| 3.2045% | |
| 5.3269% | |
| 19.7443% | |
| 24.3193% | |
| 25.9347% | |
| 24.6386% | |
| 15.3311% | |
| 34.1876% | |
| 33.5288% | |
| 28.8311% | |
| 28.2894% | |
| 5.2036% | |
| 25.002% | |
| 27.4065% | |
| 27.7246% | |
| 13.3621% | |
| -72.777% | |
| -118.6166% | |
| -144.255% | |
| -135.887% | |
| -96.8308% | |
| -89.5546% | |
| -107.9562% | |
| -43.2152% | |
| -17.9194% | |
| -4.308% | |
| 13.0508% | |
| -100.3731% | |
| -118.0851% | |
| -127.3501% | |
| -210.2261% | |
| -75.5964% | |
| -57.4284% | |
| -598.1001% | |
| -149.4449% | |
| -125.1295% | |
| -164.863% | |
| 81.8629% | |
| 60.5385% | |
| 56.8939% | |
| 67.1525% | |
| 11.6855% | |
| 40.0642% | |
| 56.5156% | |
| 60.4441% | |
| 57.8421% | |
| 43.1541% | |
| 2.2337% | |
| -62.8034% | |
| -130.2348% | |
| -259.5623% | |
| -139.3766% | |
| -128.7594% | |
| -67.0934% | |
| -39.8634% | |
| -352.265% | |
| -117.2553% | |
| -24.1865% | |
| 89.2103% | |
| 87.6512% | |
| 79.7075% | |
| 51.3554% | |
| 28.3708% | |
| -22.7294% | |
| -85.7335% | |
| -103.5723% | |
| -43.7423% | |
| 62.7521% | |
| 70.6813% | |
| 73.1045% | |
| 64.8505% | |
| -366.4322% | |
| -316.9489% | |
| 12.2611% | |
| 13.4758% | |
| 79.6791% | |
| 76.2431% | |
| -286% | |
| -179.1045% | |
| -156.1644% | |
| -138.1579% | |
| 23.0769% | |
| -11.6667% | |
| -2.8169% | |
| -6.4426% | |
| 19.0535% | |
| 20.1065% |